A protein-protein interaction map reveals that the Coxiella burnetii effector CirB inhibits host proteasome activity.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
07 2022
Historique:
received: 18 03 2022
accepted: 09 06 2022
entrez: 11 7 2022
pubmed: 12 7 2022
medline: 14 7 2022
Statut: epublish

Résumé

Coxiella burnetii is the etiological agent of the zoonotic disease Q fever, which is featured by its ability to replicate in acid vacuoles resembling the lysosomal network. One key virulence determinant of C. burnetii is the Dot/Icm system that transfers more than 150 effector proteins into host cells. These effectors function to construct the lysosome-like compartment permissive for bacterial replication, but the functions of most of these effectors remain elusive. In this study, we used an affinity tag purification mass spectrometry (AP-MS) approach to generate a C. burnetii-human protein-protein interaction (PPI) map involving 53 C. burnetii effectors and 3480 host proteins. This PPI map revealed that the C. burnetii effector CBU0425 (designated CirB) interacts with most subunits of the 20S core proteasome. We found that ectopically expressed CirB inhibits hydrolytic activity of the proteasome. In addition, overexpression of CirB in C. burnetii caused dramatic inhibition of proteasome activity in host cells, while knocking down CirB expression alleviated such inhibitory effects. Moreover, we showed that a region of CirB that spans residues 91-120 binds to the proteasome subunit PSMB5 (beta 5). Finally, PSMB5 knockdown promotes C. burnetii virulence, highlighting the importance of proteasome activity modulation during the course of C. burnetii infection.

Identifiants

pubmed: 35816513
doi: 10.1371/journal.ppat.1010660
pii: PPATHOGENS-D-22-00491
pmc: PMC9273094
doi:

Substances chimiques

Bacterial Proteins 0
Proteasome Endopeptidase Complex EC 3.4.25.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1010660

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Infect Immun. 2014 Sep;82(9):3740-52
pubmed: 24958706
Front Cell Infect Microbiol. 2017 Dec 05;7:487
pubmed: 29376029
Appl Environ Microbiol. 2019 May 30;85(12):
pubmed: 30979834
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
Cell Microbiol. 2005 Jul;7(7):981-93
pubmed: 15953030
Infect Immun. 2015 Feb;83(2):661-70
pubmed: 25422265
PLoS Pathog. 2008 Aug 01;4(8):e1000117
pubmed: 18670632
Mol Cell. 2011 Jan 7;41(1):8-19
pubmed: 21211719
Nature. 2002 May 23;417(6887):399-403
pubmed: 12000970
Science. 2019 Nov 15;366(6467):818-822
pubmed: 31727826
Cell. 2018 Dec 13;175(7):1931-1945.e18
pubmed: 30550790
PLoS Negl Trop Dis. 2021 Jul 15;15(7):e0009520
pubmed: 34264939
Nat Rev Mol Cell Biol. 2018 Nov;19(11):697-712
pubmed: 30065390
Cell Host Microbe. 2015 Jul 8;18(1):109-21
pubmed: 26118995
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21755-60
pubmed: 21098666
J Med Chem. 2019 Jan 10;62(1):359-370
pubmed: 30452262
Nature. 2011 Dec 21;481(7381):365-70
pubmed: 22190034
Int J Oncol. 2017 Feb;50(2):477-486
pubmed: 28000897
Front Genet. 2019 Oct 25;10:1053
pubmed: 31749837
J Mol Biol. 2017 Nov 10;429(22):3500-3524
pubmed: 28583440
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):E707-15
pubmed: 23382224
Autophagy. 2021 Mar;17(3):706-722
pubmed: 32116095
Biochemistry. 2002 Jun 4;41(22):7047-53
pubmed: 12033938
Nucleic Acids Res. 2019 Jan 8;47(D1):D1211-D1217
pubmed: 30252093
J Med Microbiol. 2011 Jan;60(Pt 1):9-21
pubmed: 21030501
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
PLoS Comput Biol. 2009 Sep;5(9):e1000515
pubmed: 19779545
Mol Cell Proteomics. 2021;20:100005
pubmed: 33177156
Trends Biochem Sci. 2017 May;42(5):342-354
pubmed: 28284537
J Proteomics. 2014 Apr 04;100:37-43
pubmed: 24513533
J Bacteriol. 2013 Sep;195(17):3914-24
pubmed: 23813730
Nat Rev Microbiol. 2013 Aug;11(8):561-73
pubmed: 23797173
Mol Cell. 2018 Aug 16;71(4):637-648.e5
pubmed: 30118682
Trends Biochem Sci. 2005 Jun;30(6):283-6
pubmed: 15950869
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Proc Natl Acad Sci U S A. 2016 Jun 7;113(23):E3260-9
pubmed: 27226300
PLoS Pathog. 2011 May;7(5):e1002056
pubmed: 21637816
Nature. 2006 Mar 30;440(7084):637-43
pubmed: 16554755
Nat Methods. 2013 Aug;10(8):730-6
pubmed: 23921808
EMBO Mol Med. 2017 Sep;9(9):1294-1313
pubmed: 28674081
Infect Immun. 2018 Mar 22;86(4):
pubmed: 29339460
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Cell. 1998 Feb 6;92(3):367-80
pubmed: 9476896
Infect Immun. 2016 Aug 19;84(9):2524-33
pubmed: 27324482
Nat Cell Biol. 2015 Jul;17(7):917-29
pubmed: 26075355
PLoS Pathog. 2016 Dec 21;12(12):e1006101
pubmed: 28002452
Proc Natl Acad Sci U S A. 2020 Jun 16;117(24):13708-13718
pubmed: 32482853
Methods Mol Biol. 2014;1197:329-45
pubmed: 25172290
Adv Exp Med Biol. 2012;984:249-71
pubmed: 22711636
Front Cell Infect Microbiol. 2020 Nov 05;10:599762
pubmed: 33251162
Mol Cell. 2015 Jan 22;57(2):349-60
pubmed: 25544563
Nat Biotechnol. 2004 Jan;22(1):78-85
pubmed: 14704708
Proc Jpn Acad Ser B Phys Biol Sci. 2009;85(1):12-36
pubmed: 19145068
PLoS One. 2017 Nov 27;12(11):e0188071
pubmed: 29176882
Cell Microbiol. 2013 Apr;15(4):675-87
pubmed: 23126667
Curr Protoc Bioinformatics. 2015 Mar 09;49:8.19.1-8.19.16
pubmed: 25754993
Biomolecules. 2021 Jan 05;11(1):
pubmed: 33466553
J Bacteriol. 2013 Jul;195(14):3269-76
pubmed: 23687269
Cancer Discov. 2018 Nov;8(11):1474-1489
pubmed: 30209081
J Cancer Res Clin Oncol. 2013 Jul;139(7):1105-15
pubmed: 23535871
BMC Microbiol. 2020 Aug 12;20(1):251
pubmed: 32787788
Nat Rev Mol Cell Biol. 2004 Mar;5(3):177-87
pubmed: 14990998
Proc Natl Acad Sci U S A. 2022 Jan 4;119(1):
pubmed: 34930823
PLoS Pathog. 2010 Dec 02;6(12):e1001216
pubmed: 21151961
J Proteome Res. 2017 Jan 6;16(1):170-178
pubmed: 27684284
Autophagy. 2018;14(10):1710-1725
pubmed: 29973118
Biochemistry. 2003 Jul 29;42(29):8663-70
pubmed: 12873125
PLoS Pathog. 2018 Feb 26;14(3):e1006922
pubmed: 29481553
Appl Environ Microbiol. 2011 Jun;77(11):3720-5
pubmed: 21478315
Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):E4770-9
pubmed: 24248335
Front Cell Infect Microbiol. 2017 Feb 03;7:25
pubmed: 28217558
Nat Rev Microbiol. 2017 Oct;15(10):591-605
pubmed: 28713154
Cell Microbiol. 2017 Jan;19(1):
pubmed: 27328359
Mol Biosyst. 2016 Feb;12(2):477-9
pubmed: 26661513
Mol Cells. 2017 Jul 31;40(7):441-449
pubmed: 28743182
PLoS Pathog. 2014 Jul 31;10(7):e1004286
pubmed: 25080348
J Bacteriol. 2011 Apr;193(7):1493-503
pubmed: 21216993
PLoS Pathog. 2022 Feb 8;18(2):e1010266
pubmed: 35134097

Auteurs

Mengjiao Fu (M)

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medicine Sciences, Fengtai, Beijing,China.

Yuchen Liu (Y)

State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences, Beijing Institute of Lifeomics, Beijing, China.

Guannan Wang (G)

Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, China.

Peng Wang (P)

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medicine Sciences, Fengtai, Beijing,China.

Jianing Zhang (J)

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medicine Sciences, Fengtai, Beijing,China.

Chen Chen (C)

Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California, United States of America.

Mingliang Zhao (M)

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medicine Sciences, Fengtai, Beijing,China.

Shan Zhang (S)

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medicine Sciences, Fengtai, Beijing,China.

Jun Jiao (J)

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medicine Sciences, Fengtai, Beijing,China.

Xuan Ouyang (X)

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medicine Sciences, Fengtai, Beijing,China.

Yonghui Yu (Y)

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medicine Sciences, Fengtai, Beijing,China.

Bohai Wen (B)

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medicine Sciences, Fengtai, Beijing,China.

Chengzhi He (C)

Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, China.

Jian Wang (J)

State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences, Beijing Institute of Lifeomics, Beijing, China.

Dongsheng Zhou (D)

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medicine Sciences, Fengtai, Beijing,China.

Xiaolu Xiong (X)

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medicine Sciences, Fengtai, Beijing,China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH